Authors: Oprea, TI Davis, AM Teague, SJ Leeson, PD

Citation: Ti. Oprea et al., Is there a difference between leads and drugs? A historical perspective, J CHEM INF, 41(5), 2001, pp. 1308-1315

Authors: Teague, SJ Davis, AM Leeson, PD Oprea, T

Citation: Sj. Teague et al., The design of leadlike combinatorial libraries, ANGEW CHEM, 38(24), 1999, pp. 3743-3748

Authors: Leeson, PD Rees, DC

Citation: Pd. Leeson et Dc. Rees, Next generation therapeutics - Editorial overview, CURR OP C B, 3(4), 1999, pp. 369-372

Authors: Moore, KW Bonner, K Jones, EA Emms, F Leeson, PD Marwood, R Patel, S Patel, S Rowley, M Thomas, S Carling, RW

Citation: Kw. Moore et al., 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D-4 receptors, BIOORG MED, 9(9), 1999, pp. 1285-1290

Authors: Curtis, NR Kulagowski, JJ Leeson, PD Ridgill, MP Emms, F Freedman, SB Patel, S Patel, S

Citation: Nr. Curtis et al., Synthesis and SAR of 2- and 3-substituted 7-azaindoles as potential dopamine D-4 ligands, BIOORG MED, 9(4), 1999, pp. 585-588

Authors: Carling, RW Moore, KW Moyes, CR Jones, EA Bonner, K Emms, F Marwood, R Patel, S Patel, S Fletcher, AE Beer, M Sohal, B Pike, A Leeson, PD

Citation: Rw. Carling et al., 1-(3-cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A selective high-affinity antagonist for the human dopamine D-4 receptorwith excellent selectivity over ion channels, J MED CHEM, 42(14), 1999, pp. 2706-2715